clinic
microbiolog
laboratori
increasingli
reli
molecular
diagnost
techniqu
variou
format
nucleic
acid
amplif
frequent
use
molecular
test
diagnosi
infecti
diseas
mani
clinic
set
polymeras
chain
reaction
pcr
clearli
method
choic
due
exquisit
sensit
specif
today
mani
convent
pcr
method
replac
realtim
pcr
allow
rapid
detect
quantif
pcr
product
well
detect
differ
strain
pathogen
melt
curv
analysi
abil
measur
quantiti
microb
quantit
pcr
becom
increasingli
import
provid
inform
progress
prognosi
diseas
effect
treatment
wide
use
molecular
diagnost
techniqu
isotherm
amplif
method
nucleic
acid
hybrid
techniqu
microarray
techniqu
hold
promis
except
sensit
capac
detect
sever
pathogen
simultan
howev
microarray
current
expens
adapt
routin
diagnost
diagnost
use
requir
broadbas
nucleic
acid
amplif
prior
analysi
well
establish
sever
molecular
method
use
genotyp
allow
identif
differ
subtyp
pathogen
genotyp
play
role
risk
assess
manag
infect
clinician
need
recogn
enhanc
accuraci
speed
molecular
diagnost
techniqu
diagnosi
infect
also
understand
limit
laboratori
result
alway
interpret
context
clinic
present
patient
appropri
site
qualiti
time
specimen
collect
requir
reliabl
test
result
clinic
microbiolog
laboratori
use
wide
rang
differ
techniqu
support
clinic
decisionmak
diagnosi
treatment
prognosi
infect
two
broad
approach
diagnosi
use
gold
standard
direct
detect
pathogen
clinic
sampl
collect
case
rang
method
cultur
electron
microscopi
pathogen
genom
detect
polymeras
chain
reaction
pcr
use
key
perform
issu
summar
tabl
infect
often
diagnos
indirectli
detect
patient
immun
respons
infect
detect
pathogen
specif
igm
commonli
use
method
confirm
acut
infect
today
clinic
microbiolog
diagnost
increasingli
reli
molecular
techniqu
brief
review
focu
key
featur
influenc
clinic
use
molecular
test
wide
use
techniqu
describ
advantag
disadvantag
techniqu
outlin
tabl
cycl
amplif
polymeras
chain
reaction
pcr
variou
form
pcr
frequent
use
molecular
diagnost
techniqu
diagnosi
infecti
pathogen
certain
clinic
situat
diagnosi
viral
enceph
monitor
cytomegaloviru
cmv
epsteinebarr
viru
ebv
organ
transplant
patient
pcr
transform
laboratori
investig
exquisit
sensit
specif
clearli
method
choic
pcr
allow
amplif
million
ident
dna
copi
origin
small
amount
pathogen
genom
clinic
sampl
princip
target
dna
first
extract
denatur
high
temperatur
specif
oligonucleotid
primer
anneal
dna
lower
temperatur
follow
extens
phase
dna
polymeras
enzym
copi
templat
strand
cycl
repeat
usual
time
result
million
ident
dna
copi
principl
pcr
see
figur
pcr
increasingli
appli
diagnosi
virus
bacteria
parasit
fungi
qualit
pcr
wide
use
rang
infect
includ
herpesvirus
hsv
vzv
cmv
ebv
enterovirus
parvovirus
respiratori
virus
sarscov
poxvirus
well
gener
specif
bacteri
screen
neisseria
meningitidi
streptococcu
pneumonia
bordetella
pertussi
borrelia
spp
quantit
pcr
measur
nucleic
acid
copi
number
sampl
comparison
control
known
copi
level
appli
exampl
cmv
ebv
hbv
hcv
hiv
quantif
provid
inform
progress
prognosi
diseas
effect
antivir
treatment
today
realtim
pcr
favour
methodolog
realtim
pcr
take
advantag
fluoresc
report
give
signal
new
c
convent
pcr
method
replac
realtim
pcr
allow
realtim
detect
quantif
pcr
product
well
detect
differ
strain
pathogen
c
quantit
pcr
becom
import
tool
provid
inform
progress
prognosi
diseas
effect
treatment
satu
kurkela
md
phd
medic
research
current
fellow
public
health
microbiolog
euphem
european
centr
diseas
prevent
control
ecdc
stockholm
sweden
compet
interest
none
declar
direct
proport
amount
pcr
amplicon
method
allow
realtim
detect
quantif
pcr
amplicon
follow
thermal
cycl
melt
curv
analysi
method
differenti
pcr
amplicon
accord
length
differ
guanineecytosin
content
use
altern
sequenc
detect
differ
strain
pathogen
gene
mutat
relat
antibiot
resist
eg
meticillin
resist
staphylococcu
aureu
vancomycinresist
enterococci
realtim
pcr
rapid
high
sampl
throughput
usual
sensit
specif
comparison
convent
method
convent
realtim
pcr
use
multiplex
format
allow
detect
sever
pathogen
simultan
howev
multiplex
pcr
usual
difficult
optim
sensit
specif
method
may
preferenti
certain
amplif
product
clinic
exampl
multiplex
pcr
screen
posit
blood
cultur
bacteri
pathogen
caus
sepsi
screen
respiratori
virus
nasopharyng
swab
ligas
chain
reaction
lcr
lcr
modif
pcr
method
two
adjac
probe
hybrid
one
strand
target
dna
small
gap
two
adjac
primer
recogn
highli
specif
thermost
dna
ligas
ligat
form
singl
probe
ligat
product
serv
templat
amplif
process
lcr
allow
detect
singl
base
pair
mutat
specif
common
applic
lcr
diagnost
chlamydia
trachomati
cervic
urin
sampl
unlik
pcr
isotherm
amplif
techniqu
base
distinct
enzym
requir
thermocycl
heat
cool
cycl
take
sever
hour
isotherm
amplif
rapid
usual
requir
less
hour
perform
howev
techniqu
current
fairli
expens
describ
bestknown
isotherm
amplif
method
nucleic
acid
sequencebas
amplif
nasba
nasba
analysi
figur
perform
isotherm
condit
target
rna
convert
doublestrand
dna
use
rna
polymeras
rnaseh
primer
promot
dna
act
templat
produc
multipl
copi
rna
polar
opposit
target
use
product
addit
dna
templat
nasba
also
suitabl
dna
slight
modif
earli
step
process
recent
exampl
nasba
technolog
clinic
diagnost
realtim
multiplex
nasba
assay
detect
mycoplasma
pneumonia
chlamydophila
pneumonia
legionella
spp
respiratori
specimen
transcriptionmedi
amplif
tma
principl
tma
similar
nasba
except
use
rnaseh
activ
revers
transcriptas
wherea
nasba
use
separ
enzym
due
introduct
west
nile
viru
wnv
us
sinc
screen
primari
wnv
infect
blood
donor
initi
current
tma
refer
sensit
nucleic
acid
test
commerci
avail
wnv
infect
use
larg
scale
blood
donor
screen
us
anoth
clinic
exampl
largescal
worldwid
use
tma
technolog
detect
chlamydia
trachomati
neisseria
gonorrhoea
urin
urogenit
swab
specimen
strand
displac
amplif
sda
sda
anoth
isotherm
amplif
method
first
set
primer
contain
restrict
site
anneal
dna
templat
second
primer
anneal
adjac
first
one
start
amplif
restrict
enzym
hincii
introduc
order
nick
synthes
dna
exonucleasedefici
form
klenow
fragment
escherichia
coli
dna
polymeras
start
amplif
displac
newli
synthes
strand
similar
isotherm
amplif
techniqu
amplif
process
sda
effici
sda
use
exampl
diagnosi
n
gonorrhoea
infect
femal
endocerv
swab
male
firstvoid
urin
sampl
fluoresc
situ
hybrid
fish
fish
techniqu
allow
detect
microbi
nucleic
acid
directli
sampl
cultur
sampl
without
prior
nucleic
acid
amplif
briefli
techniqu
consist
specimen
fixat
microscop
slide
hybrid
prepar
sampl
specif
fluorescentlabel
probe
visual
detect
hybrid
fluoresc
microscop
medic
microbiolog
techniqu
use
eg
determin
antibiot
resist
detect
helicobact
pylori
gastric
biopsi
specimen
identifi
bacteria
csf
staphylococcu
aureu
blood
cultur
line
probe
assay
lipa
anoth
nucleic
acid
hybrid
test
specif
oligonucleotid
probe
attach
known
locat
nitrocellulos
strip
parallel
line
hybrid
biotinlabel
pcr
product
one
wide
use
lipa
applic
rapid
detect
rifampicin
resist
mycobacterium
tuberculosi
lipa
techniqu
also
appli
detect
antivir
drugresist
mutat
hbv
advantag
disadvantag
differ
molecular
diagnost
techniqu
techniqu
advantag
disadvantag
pcr
modif
suitabl
detect
wide
varieti
pathogen
variou
modif
suitabl
wide
varieti
specimen
materi
comparison
antibodi
antigen
detect
far
sensit
specif
specimen
contamin
lead
falseposit
result
expens
eg
serolog
method
requir
meticul
work
techniqu
qualiti
control
requir
special
facil
instrument
isotherm
amplif
addit
pcr
effici
method
nasba
affect
possibl
dna
contamin
sampl
microarray
consist
twodimension
matrix
biomolecul
print
synthes
glass
silicon
plastic
nylon
membran
microarray
detect
nucleic
acid
antibodi
attach
immobil
biomolecul
eg
oligonucleotid
protein
posit
reaction
detect
highli
advanc
scanner
use
target
label
fluoresc
probe
antibodi
schemat
illustr
one
microarray
modif
baek
et
al
shown
figur
varieti
microarray
modif
vast
vari
immobil
dna
probe
threedimension
gel
drop
electrochem
detect
hybrid
without
preced
pcr
amplif
foreseen
dna
serolog
microarray
play
import
role
futur
technolog
appli
clinic
microbiolog
laboratori
sever
applic
alreadi
propos
introduc
includ
detect
rifampicinand
isoniazidresist
tuberculosi
detect
chloroquineresist
plasmodium
falciparum
herpesviru
detect
csf
genotyp
genotyp
refer
identif
variat
differ
strain
subtyp
pathogen
nucleic
acid
level
genotyp
pcr
amplicon
perform
direct
sequenc
revers
hybrid
genotypespecif
probe
restrict
fragment
length
polymorph
detect
singl
nucleotid
polymorph
mass
spectrometri
direct
sequenc
usual
consid
gold
standard
provid
accur
extens
data
genotyp
play
import
role
manag
hcv
infect
respons
treatment
consider
vari
differ
genotyp
patient
hcv
genotyp
infect
respond
better
treatment
genotyp
infect
direct
sequenc
probe
hybrid
approach
wide
use
hcv
genotyp
exampl
genotyp
current
move
routin
practic
human
papilloma
viru
hpv
type
eight
oncogen
hpv
type
respons
cervic
cancer
cervic
intraepitheli
neoplasia
worldwid
distinct
pattern
seen
differ
region
genotyp
oncogen
hpv
type
enabl
risk
assess
person
clinic
manag
earli
intervent
women
mildli
abnorm
pap
result
genotyp
also
wide
use
molecular
epidemiolog
identifi
antimicrobi
resist
highrisk
strain
mass
spectrometri
allow
measur
molecular
mass
sampl
util
variou
clinic
diagnost
set
techniqu
sampl
first
ioniz
ion
separ
accord
masstocharg
ratio
final
separ
ion
detect
accord
ion
current
ioniz
sampl
done
variou
way
matrixassist
laser
desorptionion
maldi
wide
use
genotyp
singl
nucleotid
polymorph
maldi
mass
spectrometri
import
tool
type
bacteria
virus
use
eg
detect
hypervirul
antimicrobi
drug
resist
strain
techniqu
introduc
eg
genotyp
hcv
monitor
quasispeci
cloud
variant
rna
virus
aris
mutat
time
within
viral
isol
chronic
hcv
infect
also
use
detect
hypervirul
n
meningitidi
strain
five
serogroup
frequent
associ
invas
diseas
recent
method
base
broadrang
rtpcr
follow
electrospray
ioniz
mass
spectrometri
appli
monitor
global
spread
novel
influenza
viru
genotyp
laboratori
test
microbiolog
laboratori
result
never
definit
clinic
signific
test
result
alway
place
context
patient
clinic
present
molecular
diagnost
techniqu
except
rule
inde
exquisit
sensit
pcr
add
new
issu
clinic
interpret
laboratori
result
mani
infecti
agent
caus
clinic
asymptomat
infect
exampl
noroviru
caus
gastroenter
high
rate
asymptomat
infect
systemat
applic
pcr
respiratori
enter
ill
reveal
mix
infect
common
mean
attribut
causal
singl
agent
difficult
perform
laboratori
method
defin
specif
sensit
importantli
predict
valu
sensit
assay
refer
abil
correctli
identifi
affect
individu
wherea
specif
refer
abil
correctli
identifi
nonaffect
individu
falseposit
andor
falseneg
result
molecular
diagnost
techniqu
occur
either
due
suboptim
assay
perform
sampl
contamin
wrong
specimen
materi
wrong
time
sampl
collect
addit
posit
result
may
without
clinic
signific
sometim
due
low
detect
threshold
techniqu
posit
neg
predict
valu
assay
refer
perform
test
popul
level
ie
probabl
individu
test
posit
truli
affect
individu
test
neg
truli
nonaffect
predict
valu
test
depend
sensit
specif
assay
also
preval
diseas
popul
exampl
perform
given
hiv
antibodi
test
differ
use
highrisk
group
compar
gener
popul
posit
predict
valu
fall
preval
diseas
fall
crosscontamin
specimen
sourc
error
occur
sampl
due
specimentospecimen
contamin
sampl
process
due
contamin
laboratori
reagent
pcr
main
issu
avoid
contamin
product
pcr
high
concentr
amplif
major
issu
pcr
first
introduc
led
laboratori
work
area
differ
step
pcr
physic
separ
avoid
contamin
optim
condit
personnel
never
work
amplifi
product
clean
reagent
asept
meticul
work
techniqu
requir
avoid
specimentospecimen
contamin
introduct
realtim
pcr
reduc
potenti
contamin
reduc
handl
regular
qualiti
control
assay
vital
includ
neg
intern
posit
control
well
continu
trend
analys
must
reflect
epidemiolog
pathogen
question
molecular
analys
perform
wide
varieti
specimen
includ
serum
whole
blood
cerebrospin
fluid
csf
urin
genit
swab
respiratori
swab
stool
differ
tissu
biopsi
clinic
interpret
result
must
adjust
site
patholog
type
specimen
detect
potenti
pathogen
eg
rotaviru
faecal
sampl
case
mening
may
signific
quantiti
pathogen
present
also
import
exampl
detect
cmv
nucleic
acid
blood
sign
ongo
infect
may
without
clinic
signific
healthi
individu
may
also
undergo
reactiv
therefor
quantit
cmv
pcr
method
choic
use
immunocompromis
patient
guid
treatment
appropri
collect
handl
deliveri
specimen
laboratori
vital
avoid
falseneg
result
qualiti
figur
exampl
modif
microarray
detect
human
papilloma
viru
exampl
biotinlabel
pcr
product
hybrid
immobil
oligonucleotid
chip
incub
antibiotin
antibodyconjug
gold
nanoparticl
solut
silver
enhanc
gold
nanoparticl
bound
biotin
precipit
silver
metal
particl
chip
surfac
block
light
irradi
measur
allow
detect
quantit
analysi
target
dna
time
sampl
collect
high
import
fine
exampl
pcr
test
c
trachomati
urin
earli
posttreat
test
may
result
clinic
falseposit
result
due
detect
trace
nucleic
acid
pcr
without
presenc
infecti
pathogen
sinc
shed
detect
much
longer
pcr
cultur
wrong
time
may
also
lead
falseneg
result
pcr
test
respiratori
stool
sampl
collect
late
diseas
process
viral
nucleic
acid
alreadi
clear
case
serolog
investig
may
help
diagnosi
practic
point
c
appropri
site
qualiti
time
specimen
collect
vital
reliabl
molecular
diagnost
analys
c
fulli
exploit
potenti
new
molecular
test
clinician
need
recogn
enhanc
opportun
diagnosi
also
constraint
